Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Liabilities and Shareholders Equity (2016 - 2020)

Glucotrack's Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $11.5 million for Q3 2020.

  • For the quarter ending Q3 2020, Liabilities and Shareholders Equity rose 481.3% year-over-year to $11.5 million, compared with a TTM value of $37.0 million through Dec 2020, up 431.6%, and an annual FY2019 reading of $1.1 million, up 59.26% over the prior year.
  • Liabilities and Shareholders Equity for Q3 2020 was $11.5 million at Glucotrack, down from $12.2 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $13.3 million in Q1 2020, with the low at $688186.0 in Q4 2018.
  • Average Liabilities and Shareholders Equity over 5 years is $3.9 million, with a median of $2.5 million recorded in 2018.
  • Year-over-year, Liabilities and Shareholders Equity plummeted 58.76% in 2018 and then surged 1488.97% in 2020.
  • Tracing GCTK's Liabilities and Shareholders Equity over 5 years: stood at $2.5 million in 2016, then plummeted by 32.18% to $1.7 million in 2017, then plummeted by 58.76% to $688186.0 in 2018, then skyrocketed by 59.26% to $1.1 million in 2019, then surged by 946.79% to $11.5 million in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Liabilities and Shareholders Equity are $11.5 million (Q3 2020), $12.2 million (Q2 2020), and $13.3 million (Q1 2020).